Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Susmita Roy

Mpharm (Pharmacology)

Susmita Roy, B pharm, M pharm Pharmacology, graduated from Gurunanak Institute of Pharmaceutical Science and Technology with a bachelor's degree in Pharmacy. She is currently working as an assistant professor at Haldia Institute of Pharmacy in West Bengal. She has been part of Medical Dialogues since March 2021.

Home

Susmita Roy

Articles By : Susmita Roy

Govt Panel Directs Serum Institute of India to Add Guillain-Barre Syndrome Warning as Rare Side Effect of Covishield Vaccine

Susmita Roy26 Feb 2025 8:44 PM IST

New Delhi: A panel functional under the Health Ministry has recommended that the Serum Institute of India (SII) update the product information for its...

No Eligible Successor: Centre Clarifies DCGIs Contractual Reappointment

Dr. Rajeev Singh Raghuwanshi Reappointed as Drugs Controller India on Contract Basis

Susmita Roy24 Feb 2025 10:00 AM IST

New Delhi: Through a recent notification, the Appointments Committee of the Cabinet has approved the re-employment of Dr. Rajeev Singh Raghuwanshi as...

94 Drug, Medical Product Batches Fail CDSCO Quality Tests in August

84 Formulations declared Not of Standard Quality as per data provided by states: CDSCO Drug Alert

Susmita Roy26 Jan 2025 6:00 PM IST

New Delhi: In line with the 'Not of Standard Quality' data provided by states, the apex drug regulatory body, the Central Drug Standard Control...

Drug Alert: CDSCO Flags 51 Formulations As Not Of Standard Quality

Susmita Roy25 Jan 2025 6:00 PM IST

New Delhi: In its latest drug alert, the apex drug regulatory body, the Central Drug Standard Control Organization (CDSCO), has flagged 41 medicine...

Revise MRP of drugs given custom duty relaxations in budget: NPPA directs Pharma Firms, Marketers

NPPA to set Ceiling prices of specified nicotine dose forms, seeks data from marketers

Susmita Roy20 Jan 2025 6:00 PM IST

New Delhi: Through a recent notification, the National Pharmaceutical Pricing Authority (NPPA), under the Ministry of Chemicals and Fertilizers, has...

Drug Safety Alert: IPC Flags Adverse Reactions linked to Tranexamic acid and Metoclopramide

Drug Safety Alert: Indian Pharmacopoeia Commission Flags ADR Linked To Beta blockers

Susmita Roy5 Jan 2025 6:00 PM IST

New Delhi: The Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert for the month of December, has revealed that...

Drug Alert: 41 Drug samples including Cipla's TOFAJAK tablets fail To Qualify CDSCO Test

Susmita Roy4 Jan 2025 6:00 PM IST

New Delhi: In its latest drug alert, the apex drug regulatory body, the Central Drug Standard Control Organization (CDSCO), has flagged 41 medicine...

Eli Lilly Inluriyo gets USFDA nod for adults with ER+, HER2-, ESR1-mutated advanced or metastatic breast cancer

Eli Lilly and Company gets CDSCO panel nod to import, market Tirzepatide Multiple Dose Pen

Susmita Roy17 Dec 2024 6:00 PM IST

New Delhi: The pharmaceutical major Eli Lilly and Company (India) has got the go-ahead from the Subject Expert Committee (SEC) functional under the...

Drug Safety Alert: IPC Flags Adverse Reactions to Amphotericin B and Carbimazole

Susmita Roy6 Dec 2024 6:00 PM IST

New Delhi: The Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert for the month of November, has revealed adverse...

Dr Reddys Labs receives positive EMA Committee opinion for proposed biosimilar of Prolia, Xgeva

Dr Reddys Laboratories gets CDSCO Panel Nod to import, market Tegoprazan for gastrointestinal diseases

Susmita Roy28 Nov 2024 6:00 PM IST

New Delhi: In a significant development, the pharmaceutical major Dr Reddys Laboratories has got the go-ahead from the Subject Expert Committee (SEC)...

Intas Pharma Told to Revise Phase I, III Pembrolizumab Trial Protocol

Intas Pharma gest CDSCO panel nod to manufacture, market anticancer drug Enzalutamide tablet

Susmita Roy27 Nov 2024 5:30 PM IST

New Delhi: Intas Pharma has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization...

Lupin plans to build new pharma manufacturing plant in Coral Springs

Revise protocol for Denosumab 60 mg prefilled syringe solution for injection: CDSCO Panel tells Lupin

Susmita Roy23 Nov 2024 5:30 PM IST

New Delhi: In line with the proposal presented by Lupin for conducting phase I study of Denosumab 60 mg prefilled syringe solution for injection (60...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok